In pioneering research, a team from Queen Mary University of London has for the first time identified a blood marker that could aid in the early diagnosis of myocarditis.

Myocarditis is a potentially fatal infection of the heart muscle. Currently, the diagnosis is made by biopsy, a costly, invasive test that poses a risk to the patient.

But that may soon change.

Research published in a scientific journal Circulation took the first steps towards a cheaper, faster and more effective method to detect disease.

By analyzing the blood of 34 patients with myocarditis, the researchers were able to observe the presence of T lymphocytes expressing a specific protein, cMet.

Our immune system has several defense cells.  Known by the general name of white blood cells, each one has its own characteristics.

In the control group of people without the disease, no signs of these same components in action were detected in the blood.

For the research team, this observation offers unprecedented opportunities: early detection, safe and inexpensive🇧🇷

The earlier the diagnosis is made, the better the chance of cure, preventing the patient from getting worse, and reducing deaths due to infection.

Research will continue with a larger sample of patients to confirm whether the presence of cMet occurs only in the presence of heart infection.

If confirmed, the researchers expect the new blood analysis method to be available within a year.

Source: Tec Mundo

Previous article10 essential apps for Apple TV
Next articleThe Russians began to fly twice as often to Thailand, India and Sri Lanka.


Please enter your comment!
Please enter your name here